Sonic Healthcare USA, Inc. has acquired substantially all of the assets of Cairo Diagnostics, LLC, Cairo Diagnostics NJ, LLC and Rye Management and Logistics Corp., collectively referred to as Cairo Diagnostics. The deal was announced on August 22, 2025.
Cairo Diagnostics is a provider of comprehensive hematology oncology diagnostics based in White Plains, New York and with a second laboratory in Woodcliff Lake, New Jersey.
Sonic Healthcare USA, Inc. is the U.S. operating division of Sonic Healthcare Ltd., one of the world’s largest medical diagnostics companies. Sonic Healthcare USA provides clinical and anatomic pathology services through a nationwide network.
With the closing of the transaction, Sonic Healthcare USA expects to integrate Cairo’s medically led test menu and infrastructure into its national network, supported by Sonic Healthcare USA’s logistics, payer contracting and commercial organization.
The transaction is subject to customary closing conditions and regulatory approvals. Financial terms were not disclosed.
According to data captured in the LevinPro HC database, this transaction marks the 82nd Laboratories, MRI and Dialysis transaction of the year, and the 45th in the diagnostic specialty. There were 122 Laboratories, MRI and Dialysis transactions announced during 2024, 64 of them diagnostic deals.
